ARKG News and Press, ARK Genomic Revolution ETF From 06/18/23

2023-06-18 05:52:00 ET Cathie Wood is on a roll -- again. Sure, her Ark Invest exchange-traded funds (ETFs) underperformed for a while. So far this year, though, all six of those ETFs have soared by at least 20%. Half of them are up more than 40%. Wood appears to be onto something with ...

Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (NYSEMKT: ARKK) trouncing the market so far in 2023 . However, there are some cases where analysts ful...

Shares of Teladoc Health (NYSE: TDOC) shot 5.1% higher as of 2:05 p.m. ET on Friday after growth investing star Cathie Wood revealed continued active purchases of the telemedicine pioneer's stock on Thursday. And not a little buying, either. According to her Ark Invest website...

BMO Global Asset Management Announces Annual Reinvested Distributions for BMO Exchange Traded Funds and ETF Series Canada NewsWire TORONTO , Dec. 19, 2022 /CNW/ - BMO Global Asset Management today announced the 2022 annual reinvested distributions for BMO Exchang...

Cathie Wood remains optimistic. Her ARK Invest exchange-traded funds (ETFs) have continued to scoop up stocks during the steep downturn this year. But she's apparently not optimistic about all of her ARK holdings. Wood is selling one high-flying stock. Here's why you should buy it ...

Warren Buffett famously stated that it's smart to "be fearful when others are greedy and be greedy when others are fearful." Cathie Wood stands out as a great example of an investor heeding the latter part of Buffett's advice. All of Wood's ARK Invest exchange-traded funds (ETFs) are do...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Natali_ Mis/ShutterStock.com Founder of Ark Invest Cathie Wood has had a long and interesting relationship with gene-editing stocks. With a slew of recent sales in the industry, however, the connection may b...

Almost every day, Ark Invest buys at least a handful of innovation-heavy stocks for its collection of exchange-traded funds. Ark Invest founder and CEO Cathie Wood has a lot of confidence in the genomic revolution, and in two companies in particular. Hardly a day in March has gone b...

Investing in innovation is never a bad idea since, effectively, you're investing in the future. The challenge is in knowing which businesses will succeed along the way -- and which ones won't. As with many other instances of investing in uncertain waters, exchange-traded funds (ETFs) ca...

It's been a rough year for Cathie Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) . The exchange-traded fund has fallen more than 30% so far in 2021. In this Motley Fool Live video recorded on Dec. 1 , Motley Fool contributors Keith Speights and Brian Orelli discuss w...